Aimei Health Technology Co., Ltd ( ($AFJK) ) has shared an announcement. Aimei Health Technology Co., Ltd has extended the deadline for its ...

Q3 2025 Earnings Call Transcript November 3, 2025 BioNTech SE misses on earnings expectations. Reported EPS is $-0.14 EPS, ...

Acetylation of lysine residues in the tail domain of histone H3 is well characterized, but lysine residues in the histone globular domain are also acetylated. Histone modifications in globular domain ...

Monday.com reported third-quarter financial results on Monday. The transcript from the company's earnings call has been ...

Allied Market Research published a report, titled, "Pharmacovigilance Market By Type (Services and Software), Process Flow ...

The declining Effective Load Carrying Capability of short-duration batteries creates a planning dilemma for utilities, writes ...

In our monthly Rare Stock Picks series, we're highlighting October 2025 investment picks. Click here for the list of October ...

Good afternoon, ladies and gentlemen, and welcome to the Curis Third Quarter 2025 Business Update Conference Call. [Operator Instructions] This call is being recorded on Thursday, November 6, 2025. I ...

When Instagram views began to drop across the board in early 2025, creator growth coach Brock Johnson saw an opportunity to ...

Synthekine Inc., an engineered cytokine therapeutics company, today announced positive initial results from a Phase 1a/1b clinical trial of STK-012 in first-line, PD-L1 negative nonsquamous (NSQ) ...

Curis, Inc. , a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its financial and operating ...